Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 13,826.00p on 27-01-2026 at 11:26:46
Change 74.00p 0.54%
Buy 13,826.00p
Sell 13,822.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 3.00 at 13,826.00p
Day's Volume: 168,432
Last Close: 13,752.00p
Open: 13,800.00p
ISIN: GB0009895292
Day's Range 13,736.00p - 13,886.00p
52wk Range: 9,574.00p - 14,408.00p
Market Capitalisation: £214.34b
VWAP: 13,798.85156p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 3 13,826.00p Automatic Execution
 11:26:46 - 27-Jan-26
Buy* 47 13,826.00p Automatic Execution
 11:26:46 - 27-Jan-26
Buy* 23 13,824.00p Automatic Execution
 11:26:46 - 27-Jan-26
Buy* 18 13,822.00p Automatic Execution
 11:26:45 - 27-Jan-26
Buy* 40 13,820.00p Automatic Execution
 11:26:45 - 27-Jan-26
Buy* 17 13,820.00p Automatic Execution
 11:26:45 - 27-Jan-26
Buy* 43 13,820.00p Automatic Execution
 11:26:45 - 27-Jan-26
Buy* 26 13,820.00p Automatic Execution
 11:26:45 - 27-Jan-26
Buy* 29 13,820.00p Automatic Execution
 11:26:45 - 27-Jan-26
Unknown* 0 13,816.00p SI Trade
 11:26:44 - 27-Jan-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Jan 2026 (Tue) 13,800.00 13,886.00 13,736.00 13,752.00 168,432
26th Jan 2026 (Mon) 13,642.00 13,770.00 13,560.00 13,752.00 1,555,763
23rd Jan 2026 (Fri) 13,702.00 13,704.00 13,512.00 13,580.00 1,574,503
22nd Jan 2026 (Thu) 13,540.00 13,604.00 13,428.00 13,560.00 2,673,261
21st Jan 2026 (Wed) 13,482.00 13,496.00 13,292.00 13,338.00 2,379,951
20th Jan 2026 (Tue) 13,786.00 13,786.00 13,268.00 13,520.00 3,045,271
19th Jan 2026 (Mon) 13,994.00 14,188.00 13,890.00 13,890.00 1,536,668
16th Jan 2026 (Fri) 14,020.00 14,154.00 13,972.00 14,052.00 3,712,321
15th Jan 2026 (Thu) 14,326.00 14,408.00 13,982.00 14,026.00 2,722,021
14th Jan 2026 (Wed) 14,080.00 14,396.00 14,072.00 14,346.00 3,068,095
13th Jan 2026 (Tue) 13,978.00 14,060.00 13,804.00 14,008.00 3,158,493
12th Jan 2026 (Mon) 14,036.00 14,266.00 13,882.00 14,120.00 2,193,793
9th Jan 2026 (Fri) 14,010.00 14,330.00 13,974.00 14,216.00 1,510,712
8th Jan 2026 (Thu) 14,030.00 14,292.00 14,022.00 14,176.00 2,489,065
7th Jan 2026 (Wed) 14,050.00 14,312.00 14,038.00 14,224.00 2,010,791
6th Jan 2026 (Tue) 13,400.00 14,114.00 13,392.00 14,038.00 2,053,602
5th Jan 2026 (Mon) 13,644.00 13,644.00 13,278.00 13,384.00 1,631,479
2nd Jan 2026 (Fri) 13,722.00 13,916.00 13,592.00 13,592.00 3,980,211
1st Jan 2026 (Thu) 13,790.00 13,790.00 13,790.00 13,790.00 0
31st Dec 2025 (Wed) 13,768.00 13,844.00 13,722.00 13,790.00 393,700
30th Dec 2025 (Tue) 13,712.00 13,798.00 13,696.00 13,750.00 950,185
29th Dec 2025 (Mon) 13,736.00 13,806.00 13,680.00 13,748.00 1,490,186
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
20th Jan 2026 7:00 am RNS AstraZeneca to complete direct listing on NYSE
8th Jan 2026 7:00 am RNS AZN new Head of Investor Relations Joris Silon
2nd Jan 2026 3:00 pm RNS Total Voting Rights
22nd Dec 2025 11:00 am RNS Director/PDMR Shareholding
22nd Dec 2025 11:00 am RNS Director/PDMR Shareholding
22nd Dec 2025 7:30 am RNS Enhertu granted BTD for post-neoadjuvant early BC
22nd Dec 2025 7:30 am RNS Enhertu granted BTD for post-neoadjuvant early BC
22nd Dec 2025 7:00 am RNS Update on LATIFY Phase III trial of ceralasertib
22nd Dec 2025 7:00 am RNS Update on LATIFY Phase III trial of ceralasertib
19th Dec 2025 11:00 am RNS Director/PDMR Shareholding
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: BofA raises St James's Place and Quilter

27th Jan 2026 09:44

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BRIEFING: Sage quarterly revenue up; Dr Martens sales decline

27th Jan 2026 07:59

(Alliance News) - The UK pub sector awaits a GBP100 million support package from the Treasury aimed at easing cost pressures, the Financial Times reports, while Sage posts 10% quarterly revenue growth and Dr Martens reports a dip in third-quarter revenue. Read More

PRESS: HSBC chair to join PM Starmer on China visit next week - Sky

22nd Jan 2026 12:29

(Alliance News) - HSBC Holdings Chair Brendan Nelson is among senior business figures set to travel to China with UK Prime Minister Keir Starmer next week, as the government seeks to reset relations with Beijing, Sky News reported on Thursday. Read More

Daiichi and AstraZeneca's Enhertu wins sixth approval in China

22nd Jan 2026 11:21

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Thursday said Chinese regulators have approved their jointly developed drug Enhertu to treat gastric cancer. Read More

LONDON MARKET CLOSE: Stocks rally as Trump calms Greenland rhetoric

21st Jan 2026 17:01

(Alliance News) - The FTSE 100 shrugged off a weak start to close slightly higher on Wednesday after US President Donald Trump said he would not use force to take control of Greenland, but insisted the US must still have "ownership" of it. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,204.22
Change55.37

Login to your account

Forgot Password?

Not Registered